SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
Clinical trials for SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) trials appear
Sign up with your email to follow new studies for SYSTEMIC LUPUS ERYTHEMATOSUS (SLE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for lupus patients: experimental drugs show promise in clinical trial
Disease control CompletedThis study tested two experimental drugs, VAY736 and CFZ533, in 107 people with systemic lupus erythematosus (SLE), a chronic autoimmune disease. The goal was to see if these drugs could reduce disease activity and allow patients to lower their steroid use. The trial was complete…
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 29, 2026 09:47 UTC
-
New drug shows promise for lupus brain fog in clinical trial
Symptom relief CompletedThis study tested an experimental drug called EG-501 to see if it could improve thinking and memory problems (often called brain fog) in people with lupus. About 131 adults with lupus and cognitive issues took either the drug or a placebo for 14 weeks. The goal was to measure cha…
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
Phase: PHASE2 • Sponsor: Evergreen Therapeutics, Inc. • Aim: Symptom relief
Last updated Apr 29, 2026 09:47 UTC
-
Large patient registry sheds light on APS and lupus
Knowledge-focused CompletedThis study created a registry to collect medical information from 868 patients with Anti-Phospholipid Syndrome (APS) and/or Systemic Lupus Erythematosus (SLE). The goal was to better understand these autoimmune diseases by gathering data from affected individuals. No treatments w…
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Apr 29, 2026 09:48 UTC
-
Navigator program aims to bridge lupus care gaps for minorities
Knowledge-focused CompletedThis study tested a patient navigator program for 75 minority adults with lupus. The program helped patients schedule appointments, arrange transportation, and find financial aid. The goal was to see if this support improves quality of life and medication adherence over 12 months…
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Knowledge-focused
Last updated Apr 29, 2026 09:47 UTC